By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: VisionCare’s FDA Approved Telescope Gets Implanted
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > VisionCare’s FDA Approved Telescope Gets Implanted
BusinessMedical DevicesTechnology

VisionCare’s FDA Approved Telescope Gets Implanted

HerinaAyot
HerinaAyot
Share
4 Min Read
SHARE

VisionCare Ophthalmic Technologies, Inc. is a privately-held company that researches, develops, manufactures, and markets proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and qual

VisionCare Ophthalmic Technologies, Inc. is a privately-held company that researches, develops, manufactures, and markets proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. In 2010, the FDA approved VisionCare’s most recent development by Dr. Isaac Lipshitz, the Implantable Miniature Telescope platform – the world’s smallest telescope.

The Company just announced that the first patient has received the Implantable Miniature Telescope operation indicated to improve vision in patients with end-stage age-related macular degeneration (AMD). The platform is based on wide-angle micro-optics that creates a telephoto system that magnifies objects in view. VisionCare also holds a CE mark and Israel Ministry of Health approval for distribution and sale of the device.

“Our patient’s procedure is a milestone that brings new hope and a first treatment option for our most visually debilitated AMD patients,” said Dr. Hudson, who was a principal investigator in the pivotal trial for FDA approval and lead author of the trial outcomes publications. “Patients with end-stage AMD have been underserved, and they have had limited options until now. Our patients who have exhausted all wet AMD treatment options, or who have the untreatable, advanced form of dry AMD, now have a potential for improved vision and quality of life. We’re talking more than just seeing better on the eye chart, but about being more independent in their daily activities and reconnecting with their social network of friends, family, and their community.”

More Read

More Confirmation Stents Overused
A Whole New Way To Look At Medicine And Healthcare Innovation
Alzheimer’s Drug Development: An Avant-Garde Approach
The Presidential Medical Formula–Self Contained Medical Clinics in Your Home
6 Questions: Reality Check for Healthcare Ads & Slogans

How The Procedure Works

The telescope implant is surgically placed in the capsular bag after removal of the eye’s lens. Implantation inside the eye allows the patient to see using natural eye movements in both stationary and dynamic environments. By leveraging the healthy areas of the patient’s eye, the light that enters the telescope gets magnified about 2.5 times and projected onto the portion of the retina unaffected by macular degeneration.

CentraSight Treatment Program

The first-of-kind telescope implant is essential to a new patient care program, CentraSight, for treating patients with end-stage macular degeneration. The program involves a patient management process and access to reimbursement resources for patients and physicians. The procedure is performed by a specially trained ophthalmic surgeon as an outpatient procedure.

About AMD

About 8 million people in the United States are currently diagnosed with AMD. People suffering from the disease typically experience a small blind spot in the middle of their field of view, only causing hindrance to things like reading or watching television. However, In the advanced stage of AMD, the blindness eventually expands outward to obstruct one’s ability to see completely. At least 2 million Americans currently suffer from the advanced stage.

VisionCare will be presenting its products and technologies at OneMedForum SF 2012, on January 9 – 12.

 

TAGGED:AMDminiature telescopeVisionCare
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

Readmissions: Hard to Predict Who it Will Be and Why

June 18, 2011
Image
eHealthMedical DevicesMobile HealthTechnology

Mobile Health Around the Globe: Acquapura Tests Drinking Water Purity

September 30, 2013
Health careMedical Devices

How Anesthesia Can Be Delivered With Anesthesia Machines

September 3, 2019

Tips for Your Medical Licensure Application

February 3, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?